James Atkinson v. NCI Nursing Corps and MedTox Laboratories, Inc.

CourtIntermediate Court of Appeals of West Virginia
DecidedNovember 15, 2023
Docket22-ica-233
StatusPublished

This text of James Atkinson v. NCI Nursing Corps and MedTox Laboratories, Inc. (James Atkinson v. NCI Nursing Corps and MedTox Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Intermediate Court of Appeals of West Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
James Atkinson v. NCI Nursing Corps and MedTox Laboratories, Inc., (W. Va. Ct. App. 2023).

Opinion

IN THE INTERMEDIATE COURT OF APPEALS OF WEST VIRGINIA 2023 Fall Term FILED _____________________________ November 15, 2023 No. 22-ICA-233 released at 3:00 p.m. _____________________________ EDYTHE NASH GAISER, CLERK INTERMEDIATE COURT OF APPEALS

JAMES ATKINSON, OF WEST VIRGINIA

Plaintiff Below, Petitioner, v. NCI NURSING CORPS. and MEDTOX LABORATORIES, INC., Defendants Below, Respondents. ________________________________________________________________________ Appeal from the Circuit Court of Harrison County Honorable Thomas A. Bedell, Judge Civil Action No. 22-C-130-2

REVERSED AND REMANDED ________________________________________________________________________ Submitted: October 11, 2023 Filed: November 15, 2023

Jeffrey M. Strange, Esq. Charles R. Bailey, Esq. Booth & Strange Justin C. Taylor, Esq. Clarksburg, West Virginia Bailey & Wyant, PLLC Counsel for Petitioner Charleston, West Virginia Counsel for Respondent NCI Nursing Corps.

CHIEF JUDGE GREEAR delivered the Opinion of the Court. GREEAR, Chief Judge:

Petitioner, James Atkinson appeals the October 31, 2022, order of the Circuit

Court of Harrison County granting Respondent NCI Nursing Corps.’ (“NCI”) Motion to

Dismiss. Mr. Atkinson contends that the circuit court erred in determining that he was a

“patient” of NCI under West Virginia Code § 55-7B-2 (2022) of the Medical Professional

Liability Act (“MPLA”), and in dismissing his claims for failure to comply with the pre-

suit notice required by West Virginia Code § 55-7B-6 (2003). The primary issue for

consideration by this Court is if Mr. Atkinson’s claims against NCI fall under the MPLA.

As discussed more fully below, we find that Mr. Atkinson was not a patient of NCI and,

thus, his claims are not subject to the MPLA. Accordingly, we reverse the circuit court’s

October 31, 2022, order and remand this case for further proceedings consistent with this

opinion.

I. FACTUAL AND PROCEDURAL BACKGROUND

On July 14, 2020, Mr. Atkinson, a coal mine belt supervisor and eighteen

year employee of Harrison Coal Company (“HCC”), was randomly selected 1 to submit to

a drug and alcohol screening administered by NCI nurse/technician, James Miller

(hereinafter “nurse”). As part of the screening, Mr. Atkinson was given a cup by the nurse

1 Mr. Atkinson averred, in his complaint, that his name was randomly selected by NCI. The screening took place “on the property” of HCC.

1 and instructed to go to a designated bathroom and provide a urine sample, which he handed

to the nurse upon completion. The nurse then observed the sample was in the proper

temperature range, split it into two vials, and sealed both vials with labels. Thereafter the

vials were placed in a sealed evidence bag, which was placed within a mailing envelope,

and mailed to Respondent MedTox Laboratories, Inc. (“MedTox”). 2 MedTox conducted

the urinalysis of the sample, which showed the presence of “marijuana (THC) metabolite”

in the amount of 32 ng/ml (nanograms per milliliter).

Upon receipt of these test results, HCC suspended Mr. Atkinson without pay

and, shortly thereafter, terminated his employment. Further, Mr. Atkinson’s associated

mining certifications were suspended by the West Virginia Office of Miners’ Health,

Safety and Training (“WVOMHST”). Despite the screening results, Mr. Atkinson alleged

that he “did not ingest any illegal drugs or anything else” that violated the rules and

regulations of the WVOMHST and demanded that the split sample of his urine be tested.

The split sample was then sent to Alere Laboratory, who conducted a test. That test also

showed a positive result for “THCA 24 NG/ML.”

Thereafter, on his own initiative Mr. Atkinson voluntarily submitted to a hair

follicle test. On August 3, 2020, he went to the Clarksburg MedExpress and had 1.5 inches

2 While MedTox was a named defendant in the proceedings below, it has not participated in this appeal.

2 of his hair harvested. This hair follicle test was intended to show the presence of any illegal

drugs, if any, in his bloodstream during the approximately thirty days prior to August 3,

2020. The test, paid for by Mr. Atkinson, was documented as compliant with all appropriate

lab protocols, and returned a negative result for all tested drugs, including marijuana.

Mr. Atkinson later learned of another test method that could be used to test

for the presence of illegal drugs over a longer period of time. On October 6, 2020, Mr.

Atkinson returned to MedExpress and had an approximately six-inch sample of hair

harvested for analysis at Expertox Laboratory in Winter Park, Florida. Results from that

test covered approximately a one-year timeframe and again showed negative for all twelve

drugs tested, including marijuana.

In a separate proceeding, Mr. Atkinson protested the WVOMHST

suspension of his mining certifications. During that process, the NCI nurse who conducted

the random drug screening testified that he did not conduct the drug screening in

accordance with 49 C.F.R. § 40.33(a) and (e), which require that parties collecting urine

samples from miners subscribe to a mandated list-serve and receive refresher training at

least every five years. The nurse also testified that he did not have any documentation

showing that he met the requirements set forth in 49 C.F.R. § 40.33(g), which is required

in order for an individual to be permitted to act as a collector in the drug testing program.

Mr. Atkinson alleged that this failure automatically rendered the drug screen results “null

3 and void.” However, NCI and MedTox did not void or otherwise disqualify the results of

the urinalysis.

On July 18, 2022, Mr. Atkinson filed the underlying complaint asserting

claims for “professional malpractice” (Count I), negligence (Count II), violation of statutes

(Count III), and sought punitive and other damages. On August 29, 2022, NCI filed its

Motion to Dismiss pursuant to Rules 12(b)(1) and 12(b)(6) of the West Virginia Rules of

Civil Procedure. In its Motion, NCI alleged that Mr. Atkinson’s claim “relate[d] to and

stem[ming] from his [p]rofessional [m]alpractice claims asserted in Count 1” of his

complaint was an MPLA claim and subject to the pre-suit notice requirements of West

Virginia Code § 55-7B-6.

On October 31, 2022, the court entered an order granting NCI’s Motion to

Dismiss. Specifically, the court found that Mr. Atkinson failed to comply with the

requirements of the MPLA deemed applicable thereto given the determination that NCI

was “a [health care] provider pursuant to the MPLA and their services rendered with

respect to Plaintiff qualify as [health care].” It is from the October 31, 2022, order that Mr.

Atkinson now appeals.

4 II. STANDARD OF REVIEW

“Appellate review of a circuit court's order granting a motion to dismiss a

complaint is de novo.” Syl. Pt. 2, State ex. rel McGraw v. Scott Runyan Pontiac-Buick,

Inc., 194 W. Va. 770, 461 S.E.2d 516 (1995). Moreover, “[t]he trial court, in appraising

the sufficiency of a complaint on a Rule 12(b)(6) motion, should not dismiss the complaint

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Chrystal R.M. v. Charlie A.L.
459 S.E.2d 415 (West Virginia Supreme Court, 1995)
Blankenship v. Ethicon, Inc.
656 S.E.2d 451 (West Virginia Supreme Court, 2007)
Osborne v. United States
567 S.E.2d 677 (West Virginia Supreme Court, 2002)
State Ex Rel. Cohen v. Manchin
336 S.E.2d 171 (West Virginia Supreme Court, 1985)
Rand v. Miller
408 S.E.2d 655 (West Virginia Supreme Court, 1991)
Wiggins v. Eastern Associated Coal Corp.
357 S.E.2d 745 (West Virginia Supreme Court, 1987)
Chapman v. Kane Transfer Co., Inc.
236 S.E.2d 207 (West Virginia Supreme Court, 1977)
State Ex Rel. McGraw v. Scott Runyan Pontiac-Buick, Inc.
461 S.E.2d 516 (West Virginia Supreme Court, 1995)
Vest v. Cobb
76 S.E.2d 885 (West Virginia Supreme Court, 1953)
Phillips v. Larry's Drive-In Pharmacy, Inc.
647 S.E.2d 920 (West Virginia Supreme Court, 2007)
Costello v. Christus Santa Rosa Health Care Corp.
141 S.W.3d 245 (Court of Appeals of Texas, 2004)
Smith v. Radecki
238 P.3d 111 (Alaska Supreme Court, 2010)
Kirk v. Anderson
2021 UT 41 (Utah Supreme Court, 2021)
Hill v. Wadsworth-Rittman Area Hospital
925 N.E.2d 1012 (Ohio Court of Appeals, 2009)
Kellar v. James
59 S.E. 939 (West Virginia Supreme Court, 1907)

Cite This Page — Counsel Stack

Bluebook (online)
James Atkinson v. NCI Nursing Corps and MedTox Laboratories, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/james-atkinson-v-nci-nursing-corps-and-medtox-laboratories-inc-wvactapp-2023.